Philadelphia Trust CO Biogen Inc. Transaction History

Philadelphia Trust CO

  • $1.38 Billion
  • Q3 2024

A detailed history of Philadelphia Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Philadelphia Trust CO holds 2,000 shares of BIIB stock, worth $315,380. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,000
Holding current value
$315,380
% of portfolio
0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$189.07 - $236.8 $378,140 - $473,600
2,000 New
2,000 $388,000
Q4 2021

Feb 09, 2022
SELL
$223.92 - $287.77 $588,909 - $756,835
-2,630 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$259.0 - $414.71 $10.8 Million - $17.4 Million
-41,867 Reduced 94.09%
2,630 $911,000
Q1 2021

May 14, 2021
BUY
$242.95 - $284.63 $485 - $569
2 Added 0.0%
44,497 $12.4 Million
Q4 2020

Feb 08, 2021
SELL
$236.26 - $355.63 $43,708 - $65,791
-185 Reduced 0.41%
44,495 $10.9 Million
Q3 2020

Nov 12, 2020
BUY
$264.77 - $305.71 $282,774 - $326,498
1,068 Added 2.45%
44,680 $12.7 Million
Q2 2020

Aug 14, 2020
SELL
$258.66 - $342.55 $2.38 Million - $3.15 Million
-9,194 Reduced 17.41%
43,612 $11.7 Million
Q1 2020

May 12, 2020
SELL
$268.85 - $341.04 $627,495 - $795,987
-2,334 Reduced 4.23%
52,806 $16.7 Million
Q4 2019

Feb 10, 2020
SELL
$220.06 - $304.07 $4.1 Million - $5.67 Million
-18,642 Reduced 25.27%
55,140 $16.4 Million
Q3 2019

Nov 12, 2019
SELL
$217.44 - $243.88 $997,614 - $1.12 Million
-4,588 Reduced 5.85%
73,782 $17.2 Million
Q2 2019

Aug 08, 2019
SELL
$219.29 - $241.72 $667,518 - $735,795
-3,044 Reduced 3.74%
78,370 $18.3 Million
Q1 2019

May 15, 2019
BUY
$216.71 - $338.96 $1.44 Million - $2.25 Million
6,634 Added 8.87%
81,414 $19.2 Million
Q4 2018

Feb 13, 2019
SELL
$278.5 - $352.75 $912,087 - $1.16 Million
-3,275 Reduced 4.2%
74,780 $22.5 Million
Q3 2018

Nov 14, 2018
SELL
$293.51 - $383.83 $1.21 Million - $1.58 Million
-4,128 Reduced 5.02%
78,055 $27.6 Million
Q2 2018

Aug 10, 2018
SELL
$257.52 - $306.91 $3.06 Million - $3.65 Million
-11,879 Reduced 12.63%
82,183 $23.9 Million
Q1 2018

May 14, 2018
SELL
$260.13 - $367.91 $1.56 Million - $2.21 Million
-6,001 Reduced 6.0%
94,062 $25.8 Million
Q4 2017

Feb 14, 2018
SELL
$307.64 - $344.58 $161,511 - $180,904
-525 Reduced 0.52%
100,063 $31.9 Million
Q3 2017

Nov 13, 2017
BUY
$281.15 - $329.69 $28.3 Million - $33.2 Million
100,588
100,588 $31.5 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Philadelphia Trust CO Portfolio

Follow Philadelphia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email